Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

NCT00933205 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00933205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00933205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Lead sponsor
Boehringer Ingelheim
Phase
Expanded access
Overall status
Approved for marketing
Start date
May 31, 2004
Completion date
Not reported
Enrollment
Not reported
Sites
215

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections